Medical Device

  • Headquartered in Silver Lake, Ohio, and a branch office in Eugene, Oregon, ACE Vision Group Inc. is an ophthalmic medical device company that was established in 2006 to develop and market proprietary technology to restore dynamic accommodation in an aging eye for patients seeking to reduce or eliminate their dependency on reading glasses.

  • Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focused on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA).

  • Interventional Spine®, Inc. was founded in February 2000 to solve a key problem confronting surgeons: how to address the aging population and resulting increase of fractures in patients with osteoporotic bone? Fracture fixation devices available at the time had severe limitations when used in the presence of osteoporotic bone. Interventional Spine product development was grounded on the basis of the Company's Compression (CLASP®) technology, which provides effective fixation in both normal and osteoporotic bone. Due to the superior fracture fixation characteristics of the CLASP® technology, Interventional Spine originally designed devices for the Podiatric and Orthopedic Trauma markets, successfully implanting over 4,000 Orthopedic Trauma Products in patients.

  • Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery. But each of these has its limitations. Glaucoma remains the leading cause of blindness worldwide, in need of better treatment alternatives. It is our goal to develop new and effective solutions for ophthalmology specialists and the 70 million people worldwide who are affected by this debilitating and sight-stealing disease.

  • LensGen is developing a novel solution to treat presbyopia. The LensGen product, under development, is designed to restore youthful vision to anyone over the age of 45 without spectacles, contact lenses and LASIK.

  • Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring. The recent introduction of the first-and-only FDA-cleared technology that noninvasively and continuously measures total hemoglobin without a painful needle stick and invasive blood draw is expected to open new markets and significantly expand the company’s growth opportunities.

  • MiCardia has developed a new-to-world technology platform to dynamically optimize mitral valve repair, during and after surgery, to achieve the proper shape and size necessary to produce superior clinical outcomes for each patient (implantable devices for heart valve repair). CE Mark for the enCorSQ™ Mitral Valve Repair System™ was received in September, 2011. The first patient to be adjusted was successfully treated in August, 2011, four months after implant.

  • Nexus Dx is a global provider of Near Patient Testing systems and advanced diagnostic solutions. The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most.

  • Pathway Diagnostics Ltd was established in 2000 as a manufacturing and consulting company specialising in the field of haemostasis.

  • ReShape Medical® is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients.

  • Expanding endovascular management of acute stroke and neurovascular disease, Reverse Medical is developing a broad product portfolio of unique neurovascular devices to improve treatment options and to enable faster, more accurate procedures.

  • Sequent Medical, Inc. is a developer of medical devices for the endovascular treatment of neurovascular diseases. The company develops Microbraid technology to create a web aneurysm embolization system for the treatment of both ruptured and unruptured aneurysms.

  • Silicon Valley Medical Instruments, Inc. delivers products that combine vision, elegance and simplicity to reduce procedural time, increase interventional confidence and improve patient outcomes.

  • Tandem Diabetes Care is experienced, not by age but through collaborative wisdom shared by on-staff insulin pump users, more than 4,000 clinicians and a community of people with diabetes. With the leadership from former executives of leading life science companies, Tandem is committed to creating products that enable a flexible lifestyle, are engineered to the highest quality standards and designed with uncompromising style. Tandem understands "one size does not fit all" when it comes to pump therapy and is focused in offering product choices to meet individual needs.

  • TherOx, Inc. is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients.

  • TrueVision 3D Surgical is the leader in digital 3D visualization and guidance for microsurgery. Santa Barbara, California-based TrueVision has developed and patented an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients.

  • Versant Ventures is a leading venture capital firm that specializes in investments in game changing medical devices, biopharmaceuticals, and other life science opportunities. Founded in 1999, the firm consists of an experienced team of managing directors committed to helping entrepreneurs build successful companies that impact healthcare and improve quality of life.

  • Vessix Vascular is located in Laguna Hills, California and has developed a novel radiofrequency balloon catheter technology for the treatment of uncontrolled hypertension via percutaneous renal denervation. In 2012, Vessix was acquired by Boston Scientific Corporation (NYSE: BSX).

  • WaveTec Vision is committed to developing and providing innovative wavefront measurement technology to the cataract surgeon. Through their revolutionary ORA System®, they help ophthalmologists worldwide by providing on-demand information that enables achievement of the best possible vision for their patients.